REFERENCES
- American Druggist, May 1985, p. 17.
- Drug Topics, Fcb. 17, 1985, p. 38.
- Pharmaceutical Benefits Under State Medical Assistance Programs. Washing-ton, DC: National Pharmaceutical Council, 1985.
- Vogel, R. J. (1983). AHCCCS: A new Medicare-Medicaid model in Arizona. N Eng I Med, 309, 934–6.
- Christianson, J. B. (1984). Provider panicipation in competitive bidding for indigent patients. Inquiry, 21: 161–77.
- Ellwood, P. M. (1974). Models for organizing health services and implications of legislative proposals. In, Zola, 1. K. & McKinlay, J. B. (cds.) Organizational issues in the delivery of health services. New York: Prodist, pp. 67–96.
- Johns, L., Derzon, R. A. & Anderson, M.D. (1985). Selective contracting in California: Early effects and policy implications. Inquiry, 22, 24–32.
- Yesalis, C. R., Norwood, J. & Helling, D. K. Cl al. (1984). Capitation payment for pharmacy services: Impact on costs. Med Care, 22, 746–54.
- Smith, H. A. (1980). Principles and methods of pharmacy management, 2nd cd. Philadelphia: Lea and Febiger, pp. 268–78.
- Smith, M. I. & Wertheimer, A. I. (1979). Maximum allowable cost: Can the government control drug costs? ..1 Health Politics, Policy and Law, 4, 155–75.
- Schondelmcycr, S. W. (1986). HMOs and PPOs: Strategy for success through pharmacy networks. Am Pharm, NSA, 44–55.
- Wagner, J. L. Economic evaluations of medicines: A review of the literature. Washington, DC: Pharmaceutical Manufacturers Association, 1982.
- Weiner, S. M. (1981). On public values and private regulation: Some reflections on cost containment strategics. Milbank Memorial Fund Quarterly, .59, 269–96.